Showing 257–271 of 271 results
-
XOLAIR (omalizumab) for injection, for subcutaneous use.
Read more -
XOSPATA (gilteritinib) tablets, for oral use. Initial U.S. Approval: 2018
Read more -
YERVOY (ipilimumab) injection, for intravenous use. Initial U.S. Approval: 2011
Read more -
ZAVZPRET (zavegepant) nasal spray
Read more -
ZEJULA (niraparib) capsules, for oral use. Initial U.S. Approval: 2017
Read more -
ZELBORAF (vemurafenib) tablet. FDA-Approved
Read more -
ZEPBOUND (tirzepatide) Injection
Read more -
ZEPOSIA (ozanimod) capsules, for oral use. Initial U.S. Approval: 2020
Read more -
ZIIHERA (zanidatamab-hrii) Injection
Read more -
ZILBRYSQ (zilucoplan)
Read more -
ZURZUVAE (zuranolone)
Read more -
ZycoRap SARS COV-2 Antigen Rapid Test. Get Access In India
Read more -
ZYDELIG (idelalisib) tablets, for oral use. Initial U.S. Approval: 2014
Read more -
ZYNLONTA (loncastuximab tesirine-lpyl) for injection
Read more -
ZYNYZ (retifanlimab-dlwr) Injection
Read more
